In New Jersey cases, appellate court should move to protect process that is essential to improving patient safety and health care quality. Learn more.
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the CDC's heat risk initiative and more.
Change Healthcare experiences a cyber security issue impacting prior procedure authorizations, electronic prescribing and other patient care functions.
On prior auth, scope creep, Medicare pay and more, the AMA fights to help otolaryngologists—and all physicians—so they can focus on patient care.
The goal of the Reimagining Residency grant program is to transform residency training to best address the workplace needs of our current and future health care system.
Find how the AMA ChangeMedEd® initiative focuses on increased diversity and an improved sense of belonging in medical education.
Choosing a physician specialty is a nuanced decision for any aspiring doctor. Parenting responsibilities can add another layer to that career-shaping choice.
Prep with help from Kaplan Medical. Which product is produced by the cells in a biopsy sample from a patient?
This PM&R resident’s journey in research includes training on two continents and three advanced degrees. She offers great advice for medical students.
Physician practice options can overwhelm. Learn from experienced doctors how practice setting influences autonomy, financial risk and more.
New AMA survey indicates physicians still feeling adverse impact from Change Healthcare cyberattack and more in the latest Advocacy Update spotlight.
Physicians recommend condition-focused MIPS framework and more in the latest Medicare Payment Reform Advocacy Update.
Medical students who join the AMA enjoy exclusive member benefits and perks to help them personally and professionally on their road to residency. Find out more.
Celebrate your grad’s incredible accomplishment by activating their AMA membership. Learn how.
Details provided on the application process and deadlines for physicians, residents and medical students interested in joining AMA council and committees.
Review the reports and resolutions submitted for consideration at the 2024 Annual Meeting of the AMA House of Delegates.
See how the CCB recommends changes to the AMA Constitution and Bylaws and assists in reviewing the rules, regulations and procedures of AMA sections.
Apply for a leadership position by submitting the required documentation by the deadline.
The Medical Student Section (MSS) strives to be medical students' voice within the AMA for improving medical education and advocating for the future of medicine.
In honor of Older Americans Month (May 1-31, 2024), the AMA celebrates senior physician members (ages 65 years and above).
The 2024 International Conference on Physician Health will be held Oct. 17–Oct. 19, 2024. Learn more.
This two-day boot camp Sept. 23-24, 2024, is designed for clinical and operational change agents looking to eliminate unnecessary work and free up more time to focus on what matters most–patient care.
The mission of the American Medical Association’s Substance Use and Pain Care Task Force is to promote evidence-based policy to end the epidemic of deaths related to drug overdose.
Science, evidence and compassion must guide patient care and policy change to end the drug-overdose epidemic.
The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price.
The AMA applauds the DEA extending flexibilities in the prescribing of controlled substances through telehealth visits through Nov. 11, 2023.
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.
The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.
Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.
FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.
Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.